New Horizon Health Ltd
HKEX:6606

Watchlist Manager
New Horizon Health Ltd Logo
New Horizon Health Ltd
HKEX:6606
Watchlist
Price: 14.14 HKD
Market Cap: 6.3B HKD

ROE
Return on Equity

4.4%
Current
-140%
Average
3.4%
Industry

ROE, or Return on Equity, is a key financial ratio that measures a company's profitability. Specifically, it measures how many dollars of profit are generated for each dollar of shareholder's equity. A higher ROE indicates better financial performance and effective use of capital, making it a valuable metric for investors assessing a company's earning potential.

ROE
4.4%
=
Net Income
110.6m
/
Equity
3B

ROE Across Competitors

No Stocks Found

New Horizon Health Ltd
Glance View

Market Cap
6.5B HKD
Industry
Health Care

New Horizon Health Ltd. operates as an investment holding company. The company is headquartered in Hangzhou, Zhejiang. The company went IPO on 2021-02-18. The firm distributes its ColoClear, Pupu tube and other products to customers through its own network, contracted sales organisations (CSOs) and Internet sales or e-platform operated by healthcare clinics. The Company’s Youyou Tube (a stool-based self-checking gastric cancer screening test) and CerviClear (a non-invasive urine cervical cancer home screening test) are under development.

Intrinsic Value
Not Available
What is Return on Equity?

ROE, or Return on Equity, is a key financial ratio that measures a company's profitability. Specifically, it measures how many dollars of profit are generated for each dollar of shareholder's equity. A higher ROE indicates better financial performance and effective use of capital, making it a valuable metric for investors assessing a company's earning potential.

ROE
4.4%
=
Net Income
110.6m
/
Equity
3B
What is the ROE of New Horizon Health Ltd?

Based on New Horizon Health Ltd's most recent financial statements, the company has ROE of 4.4%.

Back to Top